Relationship between insulin resistance and endothelium-dependent vascular relaxation in patients with essential hypertension

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 280-285

  Higashi, Yukihito ^a   Oshima, Tetsuya ^b   Sasaki, Nobuo ^b   Ishioka, Norio ^b   Nakano, Yukiko ^b   Ozono, Ryoji ^b   Yoshimura, Mitsuisa ^b   Ishibashi, Katsuhiko ^b   Matsuura, Hideo ^b   Kajiyama, Goro ^b  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

cyclic GMP; hypertension, essential; insulin resistance; L arginine; nitric oxide; renal circulation

Indexed keywords

ARGININE; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; GLUCOSE; INSULIN; NITRIC OXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY CIRCULATION; MALE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0031033874     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.280     Document Type: Article

References (43)

1. Morris AD, Petrie JR, Connell JMC. Insulin and hypertension. J Hypertens. 1994;12:633-642.
2. Ferrannini E, Buzzicoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Fedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
3. Sechi LA, Melis A, Tedde R. Insulin hypertension: a distinctive feature between essential and secondary hypertension. Metabolism. 1992;41:1261-1266.
4. Mordan M, Halkin H, Almong S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest. 1985;75:809-817.
5. Rowe JW, Young JB, Minaker KL, Stephens AL, Pallotta J, Landsberg L. Effects of insulin and glucose infusions on sympathetic nervous activity in normal man. Diabetes. 1981;30:219-225.
6. Bornfeldt KE, Arnqvist HJ, Capron L. In vivo proliferation of rat vascular smooth muscle in relation to diabetes mellitus, insulin-like growth factor I and insulin. Diabetologia. 1992;35:102-108.
7. DeFronzo RA, Cooke C, Andres R, Faloona GR, Davis PJ. The effect of insulin in renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest. 1975;55:845-855.
8. Vollenweider P, Randin D, Tappy L, Jequier E, Nicod P, Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest. 1994;93:2365-2371.
9. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.
10. Vanhoutte PM. Endothelium and control of vascular function. Hypertension. 1989;13:658-667.
11. Lüscher TF. Imbalance of endothelium-derived relaxing and contracting factors. Am J Hypertens. 1990;3:317-330.
12. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
13. Raij L. Nitric oxide and the kidney. Circulation. 1993;87(suppl V): V-26-V-29.
14. King AJ, Brenner BM. Endothelium-derived vasoactive factors and the renal vasculature. Am J Physiol. 1991;260:R653-R662.
15. Higashi Y, Oshima T, Ozono R, Watanabe M, Matsuura H, Kajiyama G. Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension. Hypertension. 1995;25:898-902.
16. Higashi Y, Oshima T, Ono N, Hiraga H, Yoshimura M, Watanabe M, Matsuura H, Kambe M, Kajiyama G. Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans. J Clin Endocrinol Metab. 1995;80:2198-2202.
17. Arnold WP, Mittal CK, Katuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′,5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A. 1977;74:3203-3206.
18. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
19. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
20. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468-1474.
21. Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwick GH, Selwyn AP, Ganz P, Alexander RW. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 1993; 87:86-93.
22. Manning RD, Hu L. Nitric oxide regulates renal hemodynamics and urinary sodium excretion in dogs. Hypertension. 1994;23:619-625.
23. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88:1559-1567.
24. Patel A, Layne S, Watts D, Kirchner KA. L-Arginine administration normalizes pressure natriuresis in hypertensive Dahl rats. Hypertension. 1993;22:863-869.
25. Higashi Y, Oshima T, Watanabe M, Matsuura H, Kajiyama G. Renal response to L-arginine in salt-sensitive patients with essential hypertension. Hypertension. 1996;27:634-638.
26. Petrie JR, Ueda S, Webb DJ, Elliott HL, Connell JMC. Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for pathogenesis of cardiovascular disease. Circulation. 1996;93:1331-1333.
27. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest. 1994;94:2511-2515.
28. Floyd JC, Fajans SS, Conn JW, Knopf RF, Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest. 1966;45:1487-1491.
29. Levin SR, Grodsky GM, Hagura R, Smith DF, Forsham PH. Relationships between arginine and glucose in the induction of insulin secretion from isolated, perfused rat pancreas. Endocrinology. 1972;90:624-627.
30. Cole BR, Gianiacomo J, Ingelfinger JR, Robson AM. Measurement of renal function without urine collection. N Engl J Med. 1972; 22:1109-1114.
31. Schnurr R, Lahme W, Kuppers H. Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol. 1980;13:26-29.
32. Friedman SM, Polley JR, Friedman CL. The clearance of inulin and sodium p-amino hippurate in the rat. Am J Physiol. 1947;150: 340-352.
33. Davidson W, Sackner MA. Simplification of the anthrone method for the determination of inulin in clearance studies. J Lab Clin Med. 1963;62:351-356.
34. Hollenbeck CB, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab. 1987;64:1169-1173.
35. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YI, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992;339:1128-1130.
36. Brush JE Jr, Faxon DP, Salmon S, Jacobs AK, Ryan TJ. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol. 1992;19:809-815.
37. Higashi Y, Watanabe M, Ozono R. Aging and seventy of hypertension attenuate the endothelial function in humans. Circulation. 1995;92(suppl I):I-680-I-681. Abstract.
38. Mehta S, Stewart DJ, Langleben D, Levy RD. Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. Circulation. 1995;92:1539-1545.
39. Bode-Böger SM, Böger RH, Alfke H, Heinzel D, Tsikas D, Creutzig A, Alexander K, Frölich JC. L-Arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. Circulation. 1996;93:85-90.
40. 2+ level and contraction in rat aorta: endothelium-dependent and-independent mechanism. Circ Res. 1995;77:673-678.
41. Baron AD, Zhu JS, Marshall S, Irsula O, Brechtel G, Keech C. Insulin resistance and after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats. Am J Physiol. 1995;269:E709-E715.
42. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoproteins. Nature. 1990;334:160-162.
43. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelial-derived relaxing factor by oxidized lipoproteins. J Clin Invest. 1994; 93:10-18.